Qiagen NV (NASDAQ:QGEN) shares saw an uptick in trading volume on Friday . 943,591 shares were traded during mid-day trading, an increase of 6% from the previous session’s volume of 893,382 shares.The stock last traded at $26.60 and had previously closed at $26.55.

Several research firms have recently commented on QGEN. Jefferies Group reaffirmed a “hold” rating on shares of Qiagen NV in a report on Thursday, August 4th. Zacks Investment Research lowered shares of Qiagen NV from a “hold” rating to a “sell” rating in a report on Tuesday, June 21st. DZ Bank AG reaffirmed a “buy” rating on shares of Qiagen NV in a report on Friday, July 29th. JPMorgan Chase & Co. reaffirmed a “hold” rating on shares of Qiagen NV in a report on Friday, July 29th. Finally, Mizuho lifted their price target on shares of Qiagen NV from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Monday, August 1st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $25.73.

The company has a 50 day moving average price of $25.02 and a 200-day moving average price of $22.69. The company has a market cap of $6.24 billion and a P/E ratio of 53.36.

Qiagen NV (NASDAQ:QGEN) last released its earnings results on Thursday, July 28th. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.23 by $0.01. The company had revenue of $334.40 million for the quarter, compared to analyst estimates of $326.73 million. Qiagen NV’s revenue for the quarter was up 4.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.26 earnings per share. Analysts anticipate that Qiagen NV will post $1.09 earnings per share for the current fiscal year.

A hedge fund recently raised its stake in Qiagen NV stock. Bank of Montreal Can increased its stake in shares of Qiagen NV (NASDAQ:QGEN) by 18.1% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 439,239 shares of the company’s stock after buying an additional 67,343 shares during the period. Bank of Montreal Can owned approximately 0.19% of Qiagen NV worth $12,145,000 as of its most recent filing with the SEC.

QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.